Paper41234865
CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer.
Xu B and 4 others. Transl Cancer Res, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer. Papers, record 41234865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41234865
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39422353 | Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH. | Liver Int | 2025 | https://conductscience.org/library/papers/39422353 | PubMed |
| 2 | 35541899 | SNAIL Induces EMT and Lung Metastasis of Tumours Secreting CXCL2 to Promote the Invasion of M2-Type Immunosuppressed Macrophages in Colorectal Cancer. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35541899 | PubMed |
| 3 | 36796704 | Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. | Brain Behav Immun | 2023 | https://conductscience.org/library/papers/36796704 | PubMed |
| 4 | 38602878 | IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling. | Cell Rep | 2024 | https://conductscience.org/library/papers/38602878 | PubMed |
| 5 | 40238455 | Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40238455 | PubMed |
| 6 | 40323348 | USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment. | Cancer Immunol Res | 2025 | https://conductscience.org/library/papers/40323348 | PubMed |
| 7 | 40589738 | Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40589738 | PubMed |
| 8 | 39660100 | Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis. | Genes Dis | 2025 | https://conductscience.org/library/papers/39660100 | PubMed |
| 9 | 35083551 | CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis. | J Cancer Res Clin Oncol | 2022 | https://conductscience.org/library/papers/35083551 | PubMed |
| 10 | 40683920 | Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40683920 | PubMed |
| 11 | 40372658 | Management of Stage IVB Cervical Cancer Including the Role of Radiotherapy. | Curr Treat Options Oncol | 2025 | https://conductscience.org/library/papers/40372658 | PubMed |
| 12 | 38058831 | Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/38058831 | PubMed |
| 13 | 40482404 | The Role of Radiotherapy for Metastatic Cervical Cancer: A Real-World Study. | Clin Oncol (R Coll Radiol) | 2025 | https://conductscience.org/library/papers/40482404 | PubMed |
| 14 | 40562773 | Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance. | Nat Commun | 2025 | https://conductscience.org/library/papers/40562773 | PubMed |
| 15 | 39515328 | Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy. | Cancer Cell | 2024 | https://conductscience.org/library/papers/39515328 | PubMed |
| 16 | 35008799 | High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008799 | PubMed |
| 17 | 39078728 | Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39078728 | PubMed |
| 18 | 40693230 | Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. | J Natl Cancer Cent | 2025 | https://conductscience.org/library/papers/40693230 | PubMed |
| 19 | 38942796 | Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20/CCR6 axis in human hepatocellular carcinoma. | Cell Mol Immunol | 2024 | https://conductscience.org/library/papers/38942796 | PubMed |
| 20 | 39985603 | CCL20 in the tumor microenvironment: implications for cancer progression and therapeutic approaches. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39985603 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL22 | 6367 | PubTator's text mining | https://conductscience.org/library/genes/6367 | NCBI Gene |
| CCL5 | 6352 | PubTator's text mining | https://conductscience.org/library/genes/6352 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CHD7 | 55636 | PubTator's text mining | https://conductscience.org/library/genes/55636 | NCBI Gene |
| CRYGEP | 200575 | PubTator's text mining | https://conductscience.org/library/genes/200575 | NCBI Gene |
| CXCL2 | 2920 | PubTator's text mining | https://conductscience.org/library/genes/2920 | NCBI Gene |
| CXCL3 | 2921 | PubTator's text mining | https://conductscience.org/library/genes/2921 | NCBI Gene |
| CXCL9 | 4283 | PubTator's text mining | https://conductscience.org/library/genes/4283 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41234865
GET https://conductscience.org/api/papers/v1/41234865/references?page=2